Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gallardo

Showing results (161-170 of 229) with videos related to

Pageof 23
Sort By:
Tumori|November 1, 1996
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI)A Ribas, J Bellmunt, J Albanell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 26, 2020
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)A J Muñoz Martín, E Gallardo Díaz, I García Escobar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Genomics|October 8, 1999
Genomic cloning and characterization of the human homeobox gene SIX6 reveals a cluster of SIX genes in chromosome 14 and associates SIX6 hemizygosity with bilateral anophthalmia and pituitary anomaliesM E Gallardo, J Lopez-Rios, I Fernaud-Espinosa, et al.
British Journal of Cancer|October 24, 2007
Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II studyJ Carles, A Font, B Mellado, et al.
World Journal of Urology|March 13, 2024
Nadir prostate-specific antigen after salvage cryotherapy as a potential prognostic factor for oncologic outcomesE Carbonell, C Mercader, J Sureda, et al.
Neuromuscular Disorders : NMD|December 24, 2025
Challenges in myasthenia gravis diagnosis: an analysis of the diagnostic process of myasthenia gravis in a specialized clinicA Vesperinas, J Rocaspana-Codana, D Reyes-Leiva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activityJ Bellmunt, J L González-Larriba, C Prior, et al.
Forensic Science International|May 11, 2025
Analysis of drugs of abuse and contaminants in individuals under drug surveillance programs: A study in hair samplesA Y Simão, P Y Tokuyama, G Zampieri, et al.
Revista Espanola De Cirugia Ortopedica Y Traumatologia|April 23, 2026
Influence of the scaphotrapeziotrapezoid joint on the results of total trapeziometacarpal prosthesesM R Sánchez-Crespo, H Ayala-Gutiérrez, F J Del Canto-Alvarez, et al.
Pageof 23

Showing results (161-170 of 229) with videos related to

Sort By:
Pageof 23
Tumori|November 1, 1996
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI)A Ribas, J Bellmunt, J Albanell, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 26, 2020
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)A J Muñoz Martín, E Gallardo Díaz, I García Escobar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Genomics|October 8, 1999
Genomic cloning and characterization of the human homeobox gene SIX6 reveals a cluster of SIX genes in chromosome 14 and associates SIX6 hemizygosity with bilateral anophthalmia and pituitary anomaliesM E Gallardo, J Lopez-Rios, I Fernaud-Espinosa, et al.
British Journal of Cancer|October 24, 2007
Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II studyJ Carles, A Font, B Mellado, et al.
World Journal of Urology|March 13, 2024
Nadir prostate-specific antigen after salvage cryotherapy as a potential prognostic factor for oncologic outcomesE Carbonell, C Mercader, J Sureda, et al.
Neuromuscular Disorders : NMD|December 24, 2025
Challenges in myasthenia gravis diagnosis: an analysis of the diagnostic process of myasthenia gravis in a specialized clinicA Vesperinas, J Rocaspana-Codana, D Reyes-Leiva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activityJ Bellmunt, J L González-Larriba, C Prior, et al.
Forensic Science International|May 11, 2025
Analysis of drugs of abuse and contaminants in individuals under drug surveillance programs: A study in hair samplesA Y Simão, P Y Tokuyama, G Zampieri, et al.
Revista Espanola De Cirugia Ortopedica Y Traumatologia|April 23, 2026
Influence of the scaphotrapeziotrapezoid joint on the results of total trapeziometacarpal prosthesesM R Sánchez-Crespo, H Ayala-Gutiérrez, F J Del Canto-Alvarez, et al.
Pageof 23